Overdose and Treatment: Mosapride citrate, when 100 to 330 times of the recommended clinical dose (30 to 100 mg/kg/day), was orally administered in rodents for long period (104 weeks in rats, 92 weeks in mice), increased incidence of hepatocellular adenoma and thyroid follicular cell adenoma were observed.
Since data regarding overdosage with this medication is limited, medical attention should be sought for any overdosage.